Acute myeloid leukaemia – Life with Disease

Go back

Acute myeloid leukaemia is a rapidly progressing blood cancer that requires prompt treatment and comprehensive care, bringing significant changes to daily life and demanding support from both medical teams and loved ones.

Understanding the Outlook: What to Expect with Acute Myeloid Leukaemia

Receiving a diagnosis of acute myeloid leukaemia can feel overwhelming, particularly because this is a condition that affects how well your body can produce healthy blood cells. The outlook for people with this disease varies considerably depending on several important factors. These include your age, overall health at the time of diagnosis, the specific genetic characteristics of the cancer cells, and how well your body responds to treatment.[2]

For many people, the journey with acute myeloid leukaemia involves both challenges and hope. Medical professionals measure success through something called complete remission, which means that blood cell counts return to normal levels and fewer than 5% of cells in the bone marrow are leukaemia cells.[14] Reaching this milestone is an important achievement, though it does not always mean the disease is permanently gone.

The prognosis tends to be more challenging for older adults, particularly those over 75 years of age, compared to younger patients. People with certain genetic mutations in their cancer cells may also face different outcomes than those without these changes. Your healthcare team will discuss your individual situation with you, as every person’s experience with acute myeloid leukaemia is unique.[3]

It is important to understand that despite advances in treatment, the prognosis for acute myeloid leukaemia remains difficult, especially among older populations. However, newer treatments are helping people to live longer with this condition than was possible in the past.[2] Having open conversations with your medical team about what to expect can help you prepare emotionally and practically for the road ahead.

⚠️ Important
Acute myeloid leukaemia is an aggressive cancer that develops and worsens quickly if left untreated. This means treatment usually begins within days of diagnosis. The rapid progression of symptoms is a hallmark of this condition, which is why prompt medical attention is essential.

How Acute Myeloid Leukaemia Develops Without Treatment

When acute myeloid leukaemia is left untreated, the disease progresses rapidly and can become life-threatening. The condition starts when your bone marrow, the soft tissue inside your bones responsible for making blood cells, begins producing abnormal white blood cells called myeloblasts or blasts. These abnormal cells do not function like healthy blood cells, and they multiply uncontrollably.[5]

As these leukaemia cells accumulate in your blood and bone marrow, they crowd out the space needed for healthy red blood cells, white blood cells, and platelets. Red blood cells carry oxygen throughout your body, white blood cells fight infections, and platelets help your blood clot to stop bleeding. When there is less room for these essential cells, your body cannot function properly.[8]

Without treatment, symptoms that initially might feel like a persistent cold or flu rapidly become more severe and noticeable. You might experience increasing fatigue that makes even simple tasks exhausting, frequent infections because your immune system cannot defend you properly, and easy bruising or bleeding that does not stop as it should. The anaemia caused by too few red blood cells leads to weakness, dizziness, and shortness of breath.[10]

In untreated cases, acute myeloid leukaemia can spread beyond the blood and bone marrow to other parts of the body. The leukaemia cells may travel to the central nervous system, which includes the brain and spinal cord, as well as to the skin and gums. Sometimes these cells form solid tumours called myeloid sarcomas.[5] The progression of untreated acute myeloid leukaemia represents a medical emergency, which is why doctors move quickly once a diagnosis is confirmed.

Possible Complications That May Arise

Even with treatment, acute myeloid leukaemia can lead to several complications that affect different parts of your body. Understanding these potential problems can help you recognize warning signs and seek help promptly when needed.

One of the most serious complications is a dramatically increased risk of infections. Because the leukaemia affects your white blood cells, which normally protect you from bacteria, viruses, and fungi, your body becomes vulnerable to infections that a healthy immune system would easily fight off. These infections can be severe and may require hospitalization for intravenous antibiotics or other intensive treatments.[2] Some people develop a condition called neutropenia, where the number of infection-fighting white blood cells called neutrophils drops dangerously low.

Bleeding problems represent another significant complication. With too few platelets in your blood, even minor injuries can lead to prolonged bleeding. You might notice frequent nosebleeds, bleeding gums when you brush your teeth, or tiny red spots on your skin called petechiae. More serious internal bleeding can also occur, which requires immediate medical attention.[4]

Anaemia develops when your body cannot produce enough healthy red blood cells. This leads to persistent tiredness, weakness, pale skin, and shortness of breath during activities that previously felt easy. The lack of oxygen-carrying red blood cells means your organs and tissues do not receive adequate oxygen to function optimally.[2]

Treatment for acute myeloid leukaemia, particularly intensive chemotherapy, brings its own set of complications. These can include damage to organs such as the heart, nausea and vomiting, hair loss, mouth sores, and a condition called tumour lysis syndrome where cancer cells break down so rapidly that they release harmful substances into your bloodstream. Your medical team will monitor you closely for these complications and provide supportive care to manage them.[12]

In some cases, the leukaemia may not respond to treatment or may return after initially responding. This is called refractory or recurrent disease. When this happens, additional treatment options need to be explored, and the situation becomes more complex to manage.[14]

The Impact on Your Daily Life

Living with acute myeloid leukaemia affects virtually every aspect of daily life, from physical activities to emotional wellbeing, work responsibilities, and personal relationships. The disease itself, combined with the demands of treatment, can feel like navigating through unfamiliar and challenging territory.

Physically, the fatigue associated with acute myeloid leukaemia is often profound and different from ordinary tiredness. Many people describe feeling exhausted even after rest, and simple tasks like getting dressed, preparing meals, or walking short distances may require considerable effort. This overwhelming tiredness can persist throughout treatment and for months afterward during recovery.[10] The fatigue is not just physical; it affects your ability to concentrate and make decisions, which can be frustrating when you are trying to understand treatment options and manage medical appointments.

Treatment for acute myeloid leukaemia typically requires extended hospital stays, especially during the intensive induction phase of chemotherapy. Being away from home for weeks at a time disrupts normal routines and separates you from family, friends, and familiar surroundings. When you are at home between treatment cycles, you may need to take special precautions to avoid infections, which might mean limiting contact with others, avoiding crowds, and being careful about food safety.[13]

Work and study often need to be put on hold during treatment. The demands of frequent medical appointments, the side effects of chemotherapy, and the risk of infection make it difficult or impossible to maintain regular employment or educational commitments. This interruption can create financial stress and affect your sense of identity and purpose, particularly if your work is an important part of who you are.[16]

Social activities and hobbies may become limited during treatment. The risk of infection means avoiding places where you might be exposed to germs, such as cinemas, restaurants, or public transport. Physical limitations from fatigue and other symptoms may prevent you from participating in sports or other activities you previously enjoyed. This social isolation can contribute to feelings of loneliness and disconnection from your previous life.[18]

Emotionally, the diagnosis and treatment of acute myeloid leukaemia can trigger a wide range of feelings. It is entirely normal to experience shock, fear, anger, sadness, and uncertainty about the future. Some days you might feel hopeful and determined, while other days feel overwhelming. The speed at which treatment must begin often means you have little time to process the diagnosis emotionally before facing intensive medical interventions.[16]

Relationships with family and friends may change during this time. Some people find it difficult to talk about what they are experiencing, either because they do not want to burden others or because they are unsure how to express their feelings. Conversely, you might want to talk about your experience but find that others feel uncomfortable or do not know what to say. These communication challenges can strain even close relationships.[16]

Intimacy and sexual relationships may also be affected. Treatment side effects, fatigue, and emotional stress can reduce interest in physical intimacy. Fertility concerns add another layer of worry, particularly for younger adults who hoped to have children in the future. Having honest conversations with your partner and healthcare team about these concerns is important, even though the topics may feel difficult to discuss.[18]

Despite these challenges, many people develop strategies to cope and maintain quality of life during treatment. Breaking tasks into smaller, manageable steps can help when energy is limited. Accepting help from family and friends, whether with household tasks, transportation to appointments, or simply companionship, can ease the burden. Setting small, achievable goals for each day can provide a sense of accomplishment and forward movement.[21]

⚠️ Important
Recovery from acute myeloid leukaemia treatment takes considerable time. Many people report that it takes several months to rebuild fitness and energy levels after completing treatment. This extended recovery period is normal and expected, not a sign that something is wrong. Be patient with yourself as your body heals.

Support for Family Members and Loved Ones

When someone you care about has acute myeloid leukaemia, you naturally want to help, but you might feel uncertain about the best way to provide support. Understanding what your loved one is facing, including the possibility of participating in clinical trials, can help you offer more meaningful assistance during this difficult time.

Clinical trials represent an important option in the treatment of acute myeloid leukaemia. These research studies test new treatments or new combinations of existing treatments to determine whether they are safe and effective. For people with acute myeloid leukaemia, clinical trials may offer access to cutting-edge therapies that are not yet widely available. Some trials focus on finding better initial treatments, while others explore options for people whose disease has not responded to standard treatment or has returned after remission.[5]

As a family member or friend, you can help your loved one navigate the process of considering and participating in clinical trials. Start by helping them gather information about available trials that might be suitable for their specific situation. The healthcare team can provide guidance about which trials might be appropriate based on factors such as the genetic characteristics of the leukaemia cells, previous treatments, and overall health status.

Participating in a clinical trial involves understanding detailed information about the study, including its purpose, the treatments involved, possible risks and benefits, and what will be required of participants. This information is provided in a document called an informed consent form. You can help by reading through these materials together, making notes about questions to ask, and helping your loved one understand the implications of participation. Sometimes having another person present to listen and take notes makes it easier to absorb complex medical information.[14]

Practical support is invaluable when someone is considering or participating in a clinical trial. Clinical trials often require additional appointments for monitoring and assessments beyond standard treatment visits. Offering transportation to these appointments, helping to track the schedule, and accompanying your loved one to consultations can reduce stress and ensure they do not miss important visits.

Help with organizing medical information is another practical way to support someone through clinical trial participation. This might include keeping copies of test results, maintaining a list of medications and their schedules, tracking side effects or symptoms that arise, and preparing questions before medical appointments. Having this information organized and accessible makes it easier to communicate effectively with the healthcare team.

Emotional support during clinical trial participation is equally important as practical help. Your loved one may experience a range of emotions, from hope about accessing new treatments to anxiety about unknown side effects or whether the treatment will work. Simply being present, listening without judgment, and acknowledging their feelings can provide comfort. Avoid minimizing their concerns or offering false reassurance, as this can make them feel isolated or misunderstood.[16]

Some family members worry about advocating for their loved one without overstepping. The key is to follow their lead and ask how they would like you to help. Some people want someone to speak on their behalf during medical appointments when they feel too overwhelmed or tired to communicate clearly. Others prefer to speak for themselves but appreciate having someone present to remember details or ask follow-up questions. Clarifying these preferences early helps ensure your support aligns with their needs.

It is also important to recognize that supporting someone with acute myeloid leukaemia affects your own wellbeing. Caregiving can be physically and emotionally demanding, and neglecting your own health and needs ultimately limits your ability to help. Make time for your own rest, nutrition, and activities that help you manage stress. Seeking support from other family members, friends, or caregiver support groups can help you maintain your own resilience during this challenging time.[16]

Understanding the practical realities of clinical trial participation helps you support your loved one more effectively. For example, some trials may require participants to stay in the hospital for extended periods or to return for frequent monitoring visits. Knowing these requirements in advance allows you to plan for childcare, work adjustments, or other practical matters that enable you to be present and supportive when needed most.

Finally, remember that offering support does not mean having all the answers or fixing everything. Sometimes the most valuable thing you can provide is simply being there, acknowledging the difficulty of the situation, and showing your loved one that they are not facing this journey alone. Your presence and willingness to help in whatever way is needed speaks volumes about your care and commitment.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • All-trans retinoic acid (ATRA) – Used particularly in acute promyelocytic leukaemia, this medication transforms immature white blood cells into healthy mature cells and can reduce symptoms quickly
  • Arsenic trioxide – Typically prescribed when acute promyelocytic leukaemia returns, it accelerates the death of leukaemia cells and changes immature blood cells into healthy mature cells
  • Venetoclax – Used in combination with other medications such as azacitidine, particularly for older patients or those unable to tolerate intensive chemotherapy
  • Azacitidine – A chemotherapy medicine often used in combination with other drugs for patients who cannot receive intensive treatment

Ongoing Clinical Trials on Acute myeloid leukaemia

  • A study to evaluate the safety and efficacy of ivosidenib, decitabine, and cedazuridine in adults with newly diagnosed acute myeloid leukemia who are older than 60 or cannot receive intensive chemotherapy.

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Spain
  • A Study of Ivosidenib and Azacitidine for Patients Over 55 with Acute Myeloid Leukemia and IDH1 Mutation in Complete Remission

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of gilteritinib with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed FLT3-positive acute myeloid leukemia patients

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on the Safety and Effectiveness of Fludarabine and Treosulfan for Stem Cell Transplant in Acute Myeloid Leukemia Patients Aged 40 to 65

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Italy
  • Study on WT1-loaded CBDC Vaccine for Children and Young Adults with Acute Myeloid Leukemia

    Not yet recruiting

    1 1
    Investigated diseases:
    The Netherlands
  • Study of EP0042 alone and in combination with venetoclax and azacitidine in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML)

    Not yet recruiting

    1 1 1
    The Netherlands
  • Study of venetoclax and mercaptopurine combination treatment for patients with relapsed or treatment-resistant acute myeloid leukemia

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study on the Effectiveness and Safety of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Therapy Failure

    Not yet recruiting

    1 1 1
    France Germany
  • Pharmacokinetic, Safety, and Efficacy Evaluation of ASTX727 and Venetoclax in Adult Patients with Acute Myeloid Leukemia

    Not recruiting

    1 1 1
    Investigated diseases:
    Spain
  • Study of Natural Killer Cells and Aldesleukin for Patients with Acute Myeloid Leukemia

    Not recruiting

    1 1 1
    Investigated drugs:
    The Netherlands

References

https://www.cancer.org/cancer/types/acute-myeloid-leukemia/about/what-is-aml.html

https://my.clevelandclinic.org/health/diseases/6212-acute-myeloid-leukemia-aml

https://www.ncbi.nlm.nih.gov/books/NBK507875/

https://www.mayoclinic.org/diseases-conditions/acute-myelogenous-leukemia/symptoms-causes/syc-20369109

https://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq

https://www.cancerresearchuk.org/about-cancer/acute-myeloid-leukaemia-aml

https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/leukaemia/acute-myeloid-leukaemia/

https://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq

https://www.cancer.org/cancer/types/acute-myeloid-leukemia/treating.html

https://my.clevelandclinic.org/health/diseases/6212-acute-myeloid-leukemia-aml

https://pmc.ncbi.nlm.nih.gov/articles/PMC8702813/

https://www.mayoclinic.org/diseases-conditions/acute-myelogenous-leukemia/diagnosis-treatment/drc-20369115

https://www.nhs.uk/conditions/acute-myeloid-leukaemia/treatment/

https://cancer.ca/en/cancer-information/cancer-types/acute-myeloid-leukemia-aml/treatment

https://www.mskcc.org/cancer-care/types/leukemias/treatment/acute-myeloid-leukemia

https://www.cancerresearchuk.org/about-cancer/acute-myeloid-leukaemia-aml/living-with/coping-acute-myeloid-leukaemia

https://www.cancer.org/cancer/types/acute-myeloid-leukemia/after-treatment/follow-up.html

https://www.cancerresearchuk.org/about-cancer/acute-myeloid-leukaemia-aml/living-with

https://www.webmd.com/cancer/lymphoma/acute-myeloid-leukemia-living

https://bloodcancer.org.uk/understanding-blood-cancer/leukaemia/acute-myeloid-leukaemia/life-after-aml/

https://www.healthline.com/health/aml/self-care-during-treatment

FAQ

How quickly does acute myeloid leukaemia develop?

Acute myeloid leukaemia develops rapidly, which is why it includes the word “acute” in its name. Early symptoms may feel like a persistent cold or flu, but the condition progresses quickly, and you will develop more noticeable and serious symptoms in a relatively short time. This rapid progression means treatment typically begins within days of diagnosis.

Can acute myeloid leukaemia be cured?

While chemotherapy can achieve complete remission for many people with acute myeloid leukaemia, the only established curative therapy is allogeneic stem cell transplantation. However, newer treatments are helping people live longer with this condition, and responses to treatment vary depending on individual factors such as age, overall health, and the genetic characteristics of the cancer cells.

Why does acute myeloid leukaemia cause fatigue?

The fatigue in acute myeloid leukaemia occurs because the abnormal cells crowd out healthy red blood cells in your bone marrow. Red blood cells carry oxygen throughout your body, and when there are not enough of them, your organs and tissues do not receive adequate oxygen. This condition, called anaemia, leads to weakness, tiredness, and shortness of breath.

Who is most at risk for developing acute myeloid leukaemia?

Acute myeloid leukaemia typically affects people aged 60 and older, though it can also occur in younger adults and children. Risk factors include previous chemotherapy treatment for another cancer, exposure to radiation, smoking, and inherited genetic disorders. However, in many cases, the exact cause remains unknown.

How long does recovery take after acute myeloid leukaemia treatment?

Recovery from acute myeloid leukaemia treatment takes considerable time, often several months. It is not the same as recovering from other illnesses. Your body has been through intensive treatment, and rebuilding fitness and energy levels is a gradual process. Many people report that trying to increase physical activity helps, but patience is essential as your body heals.

🎯 Key takeaways

  • Acute myeloid leukaemia is an aggressive blood cancer that develops rapidly and requires treatment to begin within days of diagnosis
  • The disease occurs when bone marrow produces abnormal white blood cells that crowd out healthy blood cells, leading to anaemia, infection risk, and bleeding problems
  • Complete remission means blood cell counts return to normal and fewer than 5% of bone marrow cells are leukaemia cells, though this does not always mean the disease is permanently gone
  • Treatment involves intensive chemotherapy in phases called induction and consolidation, with stem cell transplantation being the only established curative therapy
  • Recovery after treatment takes several months, and it is normal to need time to rebuild fitness and energy levels
  • Daily life is significantly affected during treatment, with limitations on work, social activities, and physical capabilities due to fatigue and infection risk
  • Clinical trials offer access to new treatments and may be appropriate for some patients, with family members playing an important role in supporting participation
  • Family and friends can provide valuable support through practical help with appointments, organization of medical information, and emotional presence during the treatment journey

Connected medications: